| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/11/2009 | US20090149440 1-(6-Amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isopropylaminoazetidin-1-yl)-8-methyl-4-oxo-1,4-dihydroquinolin-3-carboxylic acid; antibacterial agent; low toxicity, improved bioavailability, and low binding rate to serum proteins |
| 06/11/2009 | US20090149430 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament |
| 06/11/2009 | US20090149429 Antiviral compounds |
| 06/11/2009 | US20090149418 Antimicrobial preparations using polysaccharide gel from durian fruit-rind |
| 06/11/2009 | US20090149416 2' and 3'-Substituted Cyclobutyl Nucleoside Analogs for the Treatment Viral Infections and Abnormal Cellular Proliferation |
| 06/11/2009 | US20090149404 Oligonucleotide analogues and methods utilizing the same |
| 06/11/2009 | US20090149400 Anti-proliferative compounds, compositions, and methods of use thereof |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148531 Rate-controlled particles |
| 06/11/2009 | US20090148512 Novel uses of chloramphenicol and analogous thereof |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148499 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 06/11/2009 | US20090148497 Antibiotic Microspheres for Treatment and Prevention Of Osteomyelitis and Enhancement of Bone Regrowth |
| 06/11/2009 | US20090148492 Method of making a vascular closure device |
| 06/11/2009 | US20090148479 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 06/11/2009 | US20090148472 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/11/2009 | US20090148470 Protein-based streptococcus pneumoniae vaccines |
| 06/11/2009 | US20090148469 Multicomponent meningococcal vaccine |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148460 Exosome ligands, their preparation and uses |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148409 For improving the health of a companion animal; reducing pathogenic bacteria in feces, reducing stress, autoimmune disease, aging, kidney stones |
| 06/11/2009 | US20090148408 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 06/11/2009 | US20090148397 Compositions and Methods of Treatment With Proanthocyanidin Polymer Antidiarrheal Compositions |
| 06/11/2009 | US20090148394 Treatment of chronic ulcerous skin lesions |
| 06/11/2009 | EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/11/2009 | CA2707308A1 Ido inhibitors |
| 06/11/2009 | CA2707201A1 G immunoglobulin used against anthrax toxins |
| 06/11/2009 | CA2706155A1 Amide compounds as boosters of antivirals |
| 06/11/2009 | CA2705780A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067487A2 Immunomodulatory formulations and methods for use thereof |
| 06/10/2009 | EP2067486A1 Use of CD23 antagonists for the treatment of neoplastic disorders |
| 06/10/2009 | EP2066688A2 Macrocyclic hcv inhibitors and their uses |
| 06/10/2009 | EP2066678A1 Spiro antibiotic derivatives |
| 06/10/2009 | EP2066674A1 Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents |
| 06/10/2009 | EP2066341A1 Method of eliciting or inducing an immune response |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP2066326A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP1273587B1 Process for the preparation of a 3-vinylcephem compound |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497639C Means and methods for the production of adenovirus vectors |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497604C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497391C Humanized gene engineering antibody resisting hepatitis E virus |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497385C Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome |
| 06/10/2009 | CN100497377C SARS coronavirus structure protein ORF3 and its use |
| 06/10/2009 | CN100497376C Antimicrobial polypeptides |
| 06/10/2009 | CN100497375C Antimicrobial polypeptides |
| 06/10/2009 | CN100497370C Bursopoietin extracting method and its use in disease treating and immune |
| 06/10/2009 | CN100497356C Crystalline forms of adefovir dipivoxil ester |
| 06/10/2009 | CN100496605C Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof |
| 06/10/2009 | CN100496514C Treatment of surfaces populated by bacteria |
| 06/10/2009 | CN100496480C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544791 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | US7544699 Aryl and heteroaryl compounds, compositions, and methods of use |
| 06/09/2009 | US7544692 Dissolved in water; recrystallized, dehydrated; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus, hepatitis virus |
| 06/09/2009 | US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 06/09/2009 | US7544363 Exhibit probiotic activity in aerobic conditions; does not contribute to the production of future generation of antibiotic resistant pathogens |
| 06/09/2009 | US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/09/2009 | CA2352229C Glyceryl nucleotides, method for the production thereof and their use |
| 06/09/2009 | CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof |
| 06/09/2009 | CA2199408C Herpes simplex virus glycoprotein d variants |
| 06/04/2009 | WO2009070799A1 Processes for preparation of crystalline tigecycline form ii |
| 06/04/2009 | WO2009070779A1 Antibiotic macrocycle compounds and methods of manufacture and use thereof |
| 06/04/2009 | WO2009070564A2 Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009070307A1 Amorphous retapamulin and processes for preparation thereof |
| 06/04/2009 | WO2009070088A1 Antimicrobial polypeptide |
| 06/04/2009 | WO2009070045A2 Imidazole derivatives, process for their preparation, and thier pharmaceutical use |
| 06/04/2009 | WO2009069800A1 Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069682A1 Therapeutic agent or preventive agent for hepatitis |
| 06/04/2009 | WO2009069589A1 Novel naphthyridine derivative monohydrate and method for producing the same |
| 06/04/2009 | WO2009069448A1 Adjuvant for japanese b encephalitis vaccine, and japanese b encephalitis vaccine |
| 06/04/2009 | WO2009069447A1 Adjuvant for influenza vaccine, and influenza vaccine |
| 06/04/2009 | WO2009069352A1 Antimicrobial agent and external preparation for skin containing the same |
| 06/04/2009 | WO2009069132A2 Novel reverse transcriptase inhibitors |
| 06/04/2009 | WO2009069014A1 Amorphous lamivudine and its preparation |
| 06/04/2009 | WO2009069012A1 Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine |
| 06/04/2009 | WO2009068872A1 Antiviral |
| 06/04/2009 | WO2009067790A1 STIMULATION OF HYPOXIA INDUCIBLE FACTOR -1 ALPHA (HIF-1α) FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE (CDAD), FOR INTESTINAL MOTILITY AND FOR DETECTING INFECTION |
| 06/04/2009 | WO2009051796A3 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 06/04/2009 | WO2009048289A3 Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |